BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 28231636)

  • 1. Personalized thromboprophylaxis using a risk score for the management of pregnancies with high risk of thrombosis: a prospective clinical study.
    Dargaud Y; Rugeri L; Fleury C; Battie C; Gaucherand P; Huissoud C; Rudigoz RC; Desmurs-Clavel H; Ninet J; Trzeciak MC
    J Thromb Haemost; 2017 May; 15(5):897-906. PubMed ID: 28231636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A risk score for the management of pregnant women with increased risk of venous thromboembolism: a multicentre prospective study.
    Dargaud Y; Rugeri L; Vergnes MC; Arnuti B; Miranda P; Negrier C; Bestion A; Desmurs-Clavel H; Ninet J; Gaucherand P; Rudigoz RC; Berland M; Champion F; Trzeciak MC
    Br J Haematol; 2009 Jun; 145(6):825-35. PubMed ID: 19388925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
    Bates SM; Greer IA; Pabinger I; Sofaer S; Hirsh J
    Chest; 2008 Jun; 133(6 Suppl):844S-886S. PubMed ID: 18574280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-molecular-weight heparin to prevent recurrent venous thromboembolism in pregnancy: Rationale and design of the Highlow study, a randomised trial of two doses.
    Bleker SM; Buchmüller A; Chauleur C; Ní Áinle F; Donnelly J; Verhamme P; Jacobsen AF; Ganzevoort W; Prins M; Beyer-Westendorf J; DeSancho M; Konstantinides S; Pabinger I; Rodger M; Decousus H; Middeldorp S
    Thromb Res; 2016 Aug; 144():62-8. PubMed ID: 27289488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk stratification and heparin prophylaxis to prevent venous thromboembolism in pregnant women.
    Bauersachs RM; Dudenhausen J; Faridi A; Fischer T; Fung S; Geisen U; Harenberg J; Herchenhan E; Keller F; Kemkes-Matthes B; Schinzel H; Spannagl M; Thaler CJ;
    Thromb Haemost; 2007 Dec; 98(6):1237-45. PubMed ID: 18064320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness and safety of thromboprophylaxis with enoxaparin for prevention of pregnancy-associated venous thromboembolism.
    Cox S; Eslick R; McLintock C
    J Thromb Haemost; 2019 Jul; 17(7):1160-1170. PubMed ID: 31013386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Venous thromboembolism prophylaxis for women at risk during pregnancy and the early postnatal period.
    Middleton P; Shepherd E; Gomersall JC
    Cochrane Database Syst Rev; 2021 Mar; 3(3):CD001689. PubMed ID: 33779986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The incidence and risk factors of recurrent venous thromboembolism during pregnancy.
    Galambosi PJ; Ulander VM; Kaaja RJ
    Thromb Res; 2014 Aug; 134(2):240-5. PubMed ID: 24835671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Longitudinal Study of Thrombosis and Bleeding Outcomes With Thromboprophylaxis in Pregnant Women at Intermediate and High Risk of VTE.
    Schapkaitz E; Libhaber E; Gerber A; Rhemtula H; Zamparini J; Jacobson BF; Büller HR
    Clin Appl Thromb Hemost; 2023; 29():10760296231160748. PubMed ID: 36972476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pregnancy-Related Venous Thromboembolism.
    Armstrong EM; Bellone JM; Hornsby LB; Treadway S; Phillippe HM
    J Pharm Pract; 2014 Jun; 27(3):243-52. PubMed ID: 24742932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of unfractionated heparin versus low-molecular-weight heparin and fondaparinux for pharmacologic venous thromboembolic prophylaxis in critically ill patients with cancer.
    Van Matre ET; Reynolds PM; MacLaren R; Mueller SW; Wright GC; Moss M; Burnham EL; Ho PM; Vandivier RW; Kiser TH
    J Thromb Haemost; 2018 Dec; 16(12):2492-2500. PubMed ID: 30347498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylaxis with low-dose low-molecular-weight heparin during pregnancy and postpartum: is it effective?
    Roeters van Lennep JE; Meijer E; Klumper FJ; Middeldorp JM; Bloemenkamp KW; Middeldorp S
    J Thromb Haemost; 2011 Mar; 9(3):473-80. PubMed ID: 21232006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery.
    Felder S; Rasmussen MS; King R; Sklow B; Kwaan M; Madoff R; Jensen C
    Cochrane Database Syst Rev; 2019 Mar; 3(3):CD004318. PubMed ID: 30916777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin K Antagonists Compared to Low-Molecular-Weight Heparins for Treatment of Cancer-Associated Venous Thromboembolism: An Observational Study in Routine Clinical Practice. An Observational Study in Routine Clinical Practice.
    den Exter PL; Hooijer J; van der Hulle T; van Oosten JP; Dekkers OM; Klok FA; Huisman MV
    Thromb Haemost; 2017 Nov; 117(11):2163-2167. PubMed ID: 28981552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is low-molecular-weight heparin safe for venous thromboembolism prophylaxis in patients with traumatic brain injury? A Western Trauma Association multicenter study.
    Kwiatt ME; Patel MS; Ross SE; Lachant MT; MacNew HG; Ochsner MG; Norwood SH; Speier L; Kozar R; Gerber JA; Rowell S; Krishnakumar S; Livingston DH; Manis G; Haan JM
    J Trauma Acute Care Surg; 2012 Sep; 73(3):625-8. PubMed ID: 22929493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery.
    Felder S; Rasmussen MS; King R; Sklow B; Kwaan M; Madoff R; Jensen C
    Cochrane Database Syst Rev; 2018 Nov; 11(11):CD004318. PubMed ID: 30481366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between prophylactic low-molecular-weight heparin use in pregnancy and macrosomia: analysis of the Ottawa and Kingston birth cohort.
    Lowry DE; Corsi DJ; White RR; Guo M; Lanes A; Smith G; Rodger M; Wen SW; Walker M; Gaudet L
    J Thromb Haemost; 2019 Feb; 17(2):345-349. PubMed ID: 30552749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Venous thromboembolism in pregnancy: diagnosis, management and prevention.
    Chunilal SD; Bates SM
    Thromb Haemost; 2009 Mar; 101(3):428-38. PubMed ID: 19277402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-molecular-weight heparin to prevent postpartum venous thromboembolism. A pilot randomised placebo-controlled trial.
    Rodger MA; Phillips P; Kahn SR; James AH; Konkle BA;
    Thromb Haemost; 2015 Jan; 113(1):212-6. PubMed ID: 25373438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy.
    Di Nisio M; Porreca E; Candeloro M; De Tursi M; Russi I; Rutjes AW
    Cochrane Database Syst Rev; 2016 Dec; 12(12):CD008500. PubMed ID: 27906452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.